相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial
Shlomo Almog et al.
EUROPEAN JOURNAL OF PAIN (2020)
The anti-inflammatory and analgesic effects of formulated full-spectrum cannabis extract in the treatment of neuropathic pain associated with multiple sclerosis
Zaid H. Maayah et al.
INFLAMMATION RESEARCH (2020)
Cannabis treatment in hospitalized patients using the SYQE inhaler: Results of a pilot open-label study
Simon Vulfsons et al.
PALLIATIVE & SUPPORTIVE CARE (2020)
An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia
Tine van de Donk et al.
PAIN (2019)
Human Pharmacokinetic Parameters of Orally Administered Δ9-Tetrahydrocannabinol Capsules Are Altered by Fed Versus Fasted Conditions and Sex Differences
Stephanie Lunn et al.
CANNABIS AND CANNABINOID RESEARCH (2019)
Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective
Ziva D. Cooper et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Pharmacology of cannabinoids in the treatment of epilepsy
Tyler E. Gaston et al.
EPILEPSY & BEHAVIOR (2017)
Long-term hippocampal glutamate synapse and astrocyte dysfunctions underlying the altered phenotype induced by adolescent THC treatment in male rats
Erica Zamberletti et al.
PHARMACOLOGICAL RESEARCH (2016)
Vaping cannabis (marijuana): parallel concerns to e-cigs?
Alan J. Budney et al.
ADDICTION (2015)
Effects of cannabis on cognition in patients with MS A psychometric and MRI study
Bennis Pavisian et al.
NEUROLOGY (2014)
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial
Jody Corey-Bloom et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2012)
Gender-related differences in functional connectivity in multiple sclerosis
Menno M. Schoonheim et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Subjective and Physiological Effects After Controlled Sativex and Oral THC Administration
E. L. Karschner et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids
Paul Smith
Therapeutics and Clinical Risk Management (2010)
Neuroprotective actions of selective estrogen receptor modulators
Lydia L. DonCarlos et al.
PSYCHONEUROENDOCRINOLOGY (2009)
Multiple sclerosis and cannabis - A cognitive and psychiatric study
Omar Ghaffar et al.
NEUROLOGY (2008)
Effects of cannabis on pulmonary structure, function and symptoms
Sarah Aldington et al.
THORAX (2007)
Human cannabinoid pharmacokinetics
Marilyn A. Huestis
CHEMISTRY & BIODIVERSITY (2007)
Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis
G Savettieri et al.
JOURNAL OF NEUROLOGY (2004)
Sex differences in cognitive impairment in multiple sclerosis
WW Beatty et al.
CLINICAL NEUROPSYCHOLOGIST (2002)
Comparison of multiple DNA adduct types in tumor adjacent human lung tissue: effect of cigarette smoking
R Godschalk et al.
CARCINOGENESIS (2002)
Respiratory and immunologic consequences of marijuana smoking
DP Tashkin et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
分享论文
